These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15107401)

  • 1. Cip/Kip proteins: more than just CDKs inhibitors.
    Denicourt C; Dowdy SF
    Genes Dev; 2004 Apr; 18(8):851-5. PubMed ID: 15107401
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expression of cyclin-dependent kinase inhibitors in leukemia].
    Polák J; Peková S; Schwarz J; Kozák T; Haskovec C
    Cas Lek Cesk; 2003 Jan; 142(1):25-8. PubMed ID: 12693294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase inhibitors--a novel class of prognostic indicators.
    Palazzo JP
    Hum Pathol; 2001 Aug; 32(8):769-70. PubMed ID: 11521217
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of cyclin-dependent kinase inhibitors in taste buds of mouse and hamster.
    Hirota M; Ito T; Okudela K; Kawabe R; Hayashi H; Yazawa T; Fujita K; Kitamura H
    Tissue Cell; 2001 Feb; 33(1):25-32. PubMed ID: 11292167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of the Cip/Kip family.
    Hengst L; Reed SI
    Curr Top Microbiol Immunol; 1998; 227():25-41. PubMed ID: 9479824
    [No Abstract]   [Full Text] [Related]  

  • 6. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy.
    Verdoodt B; Blazek T; Rauch P; Schuler G; Steinkasserer A; Lutz MB; Funk JO
    Eur J Immunol; 2003 Nov; 33(11):3154-63. PubMed ID: 14579284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-cycle molecules in mesothelioma: an overview.
    Spugnini EP; Campioni M; D'Avino A; Caruso G; Citro G; Baldi A
    J Exp Clin Cancer Res; 2007 Dec; 26(4):443-9. PubMed ID: 18365537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Ol-KIP, a cyclin-dependent kinase inhibitor, in embryonic and adult medaka (Oryzias latipes) central nervous system.
    Nguyên V; Candal Suárez EM; Sharif A; Joly JS; Bourrat F
    Dev Dyn; 2001 Nov; 222(3):439-49. PubMed ID: 11747078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development.
    Nakayama K; Nakayama K
    Bioessays; 1998 Dec; 20(12):1020-9. PubMed ID: 10048302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the expression of the Cip/Kip family of cyclin-dependent kinase inhibitors in foetal developing lungs of hamsters.
    Ikoma T; Ito T; Okudela K; Hayashi H; Yazawa T; Kitamura H
    Cell Prolif; 2001 Aug; 34(4):233-41. PubMed ID: 11529881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer: Kip moving.
    Collard JG
    Nature; 2004 Apr; 428(6984):705-8. PubMed ID: 15085115
    [No Abstract]   [Full Text] [Related]  

  • 12. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?
    Coqueret O
    Trends Cell Biol; 2003 Feb; 13(2):65-70. PubMed ID: 12559756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclin-dependent kinase pathway moves forward.
    Bornfeldt KE
    Circ Res; 2003 Mar; 92(4):345-7. PubMed ID: 12623871
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinuses.
    Affolter A; Helmbrecht S; Finger S; Hörmann K; Götte K
    Oncol Rep; 2005 Jun; 13(6):1089-94. PubMed ID: 15870926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of p27 and p21 in canine cutaneous mast cell tumors and histiocytomas.
    Wu H; Hayashi T; Inoue M
    Vet Pathol; 2004 May; 41(3):296-9. PubMed ID: 15133184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p27kip1 contributions to cancer.
    Nho RS; Sheaff RJ
    Prog Cell Cycle Res; 2003; 5():249-59. PubMed ID: 14593719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions. correlation with cell cycle regulatory proteins.
    Peschos D; Tsanou E; Stefanou D; Damala C; Vougiouklakis T; Mitselou A; Agnantis NJ
    In Vivo; 2004; 18(6):719-24. PubMed ID: 15646812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
    Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML.
    Brakensiek K; Länger F; Kreipe H; Lehmann U
    Leuk Res; 2005 Nov; 29(11):1357-60. PubMed ID: 15936816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.